Neurocare Group names Tariq El-Titi as Senior VP for MENA
Neurocare Group, a leading health-tech solutions provider, has appointed Tariq El-Titi as the Senior Vice President for the Middle East and North Africa region, effective May 2024.
In his new role, Tariq brings over 30 years of leadership experience across finance, technology, HR, consulting, and health-tech sectors. He has held key positions in leading organisations, including private and publicly listed MNCs, startups, and semi-government entities across the UK, Europe, and the Middle East. He also played a pivotal role in spearheading healthcare initiatives such as Dubai Healthcare City, Mubadala Healthcare's Cleveland Clinic Abu Dhabi, and Proximie.
On the academic front, Tariq holds an MBA degree from London Business School, a bachelor's degree in business studies from the University of Westminster, and a certificate in the fundamentals of an MBA from Columbia Business School. He is also a certified Associate Chartered Management Accountant under the Chartered Institute of Management Accountants (CIMA).
Welcoming Tariq to the leadership team, Thomas Mechtersheimer, CEO of Neurocare Group, said, “We warmly welcome Tariq to the Neurocare team. His proven track record and strategic vision align perfectly with our commitment to investing in growth and cultivating strong leadership. With Tariq’s expertise, we are poised to expand our footprint in the MENA region, furthering our mission of innovating personalised mental health treatments and creating a positive health impact within the region.”
You may also like:
- Unlocking effective talent management in healthtech: Insights from Nitin Thakur
- AI evolution in the Middle East workplaces: How prepared are talent and HR? Insights from Lars Gehrmann
Tariq added, 'Global awareness and understanding around mental health have significantly increased over recent years. With changing stigmas surrounding mental health, the need for innovative solutions has never been more pressing. I am pleased and delighted to join Tom and the global Neurocare leadership team to bring much-needed success.”